Jinan High-tech Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 09:37 pm IST
Share
Jinan High-tech Development Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 320.78 million compared to CNY 247.95 million a year ago. Revenue was CNY 320.78 million compared to CNY 249.19 million a year ago. Net loss was CNY 138.24 million compared to CNY 71.44 million a year ago. Basic loss per share from continuing operations was CNY 0.16 compared to CNY 0.08 a year ago. Diluted loss per share from continuing operations was CNY 0.16 compared to CNY 0.08 a year ago.
Jinan High-tech Development Co Ltd is a China-based company principally engaged in the in vitro diagnostics business. The Company operates three segments. The Real Estate and Property Services Business segment is mainly engaged in real estate development and sales and the provision of property and property leasing services. The In Vitro Diagnostics Business segment is mainly engaged in the research and development, production and sales of products such as molecular diagnostic reagents, molecular diagnostic automated testing equipment, biological sample library management software, biological sample intelligent storage cabinets, biological sample intelligent management terminals, and provides medical testing services. The products are mainly used in the fields of infectious disease prevention and control, pathogenic microorganism detection, food safety testing and other fields. The Other Business segment is mainly engaged in trading business and other businesses.